Home/Filings/4/0001415889-18-000544
4//SEC Filing

Varvaro Thomas C 4

Accession 0001415889-18-000544

CIK 0001109196other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 9:16 PM ET

Size

7.3 KB

Accession

0001415889-18-000544

Insider Transaction Report

Form 4
Period: 2018-04-03
Transactions
  • Exercise/Conversion

    Common Stock

    2018-04-03+51323,063 total
  • Exercise/Conversion

    Restricted Stock Unit

    2018-04-035130 total
    Common Stock (513 underlying)
Footnotes (3)
  • [F1]Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 3, 2015.
  • [F2]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
  • [F3]Restricted Stock Units vest over 3 years from April 3, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date

Issuer

MABVAX THERAPEUTICS HOLDINGS, INC.

CIK 0001109196

Entity typeother

Related Parties

1
  • filerCIK 0001437495

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 9:16 PM ET
Size
7.3 KB